Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Pharmaceuticals & Biotechnology | Small Cap
Health Score : 5.52Jeena Sikho Lifecare Ltd shows a mixed financial performance. The company demonstrates strong profitability, driven by impressive gross profit and operating margins, return on capital employed, and return on equity. Its solvency position is also strong, indicating a low reliance on debt. However, liquidity is a concern, as the company struggles to maintain adequate levels of current assets to cover short-term liabilities. Efficiency ratios are also mixed, with some areas needing improvements. The company faced significant revenue decline recently, impacting overall growth. While interest coverage is adequate, dividend coverage is weak. The financial ratios reflect low earnings and book value per share, offset partly by significant capital expenditure. Overall, the company excels in profitability and solvency but needs to address its liquidity and growth challenges to ensure long-term financial stability.
Health Score : 5.52Jeena Sikho Lifecare Ltd shows a mixed financial performance. The company demonstrates strong profitability, driven by impressive gross profit and operating margins, return on capital employed, and return on equity. Its solvency position is also strong, indicating a low reliance on debt. However, liquidity is a concern, as the company struggles to maintain adequate levels of current assets to cover short-term liabilities. Efficiency ratios are also mixed, with some areas needing improvements. The company faced significant revenue decline recently, impacting overall growth. While interest coverage is adequate, dividend coverage is weak. The financial ratios reflect low earnings and book value per share, offset partly by significant capital expenditure. Overall, the company excels in profitability and solvency but needs to address its liquidity and growth challenges to ensure long-term financial stability.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
28.17
Industry Median
30.91
Small Cap Median
28.64
P/E RATIO
28.20
P/B RATIO
13.39
Industry Median
3.69
Small Cap Median
3.11
P/S RATIO
7.67
Industry Median
3.74
Small Cap Median
3.02
Others
PEG RATIO
0.00
EV/EBITDA RATIO
17.21
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹503.45 as on Sep 1, 2026.
Growth Score : 4.00The company's growth ratios reflect decline in key areas. There is a strong growth in net income, which is a positive sign. The challenges in revenue, operating profit, EPS, and asset growth indicate potential difficulties in expanding its operations and market presence. A focus on sustainable growth strategies is essential for long-term success.
Revenue Growth RatePoorOperating Profit Growth RatePoorEarnings Per Share (EPS) GrowthPoorAsset Growth RatePoor
Net Income Growth RateExcellent| Growth Ratios | Mar 2023 | Mar 2026 |
|---|---|---|
| Revenue Growth Rate | 39.46 | 70.79 |
| Operating Profit Growth Rate | 155.56 | 147.52 |
| Earnings Per Share (EPS) Growth | 121.14 | 177.6 |
| Asset Growth Rate | 143.55 | 60.86 |
| Net Income Growth Rate | 209.09 | 177.5 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Granules India Ltd | 7.73 | 34.87 | Highly Overvalued | 1185.00 | 16.17 | 595.00 |
| 2 | FDC Ltd | 7.64 | 19.29 | Neutral | 346.00 | 17.56 | 281.00 |
| 3 | Supriya Lifescience Ltd | 7.46 | 30.91 | Overvalued | 294.00 | 25.98 | 209.00 |
| 4 | Aarti Pharmalabs Ltd | 7.46 | 44.90 | Neutral | 369.00 | 19.43 | 175.00 |
| 5 | Innova Captab Ltd | 7.36 | 43.37 | Overvalued | 243.00 | 14.63 | 141.00 |
| 6 | Akums Drugs & Pharmaceuticals Ltd | 7.28 | 48.06 | Overvalued | 522.00 | 7.09 | 256.00 |
| 7 | Marksans Pharma Ltd | 7.24 | 34.97 | Neutral | 601.00 | 6.64 | 420.00 |
| 8 | Aarti Drugs Ltd | 7.20 | 20.00 | Undervalued | 309.00 | 18.54 | 195.00 |
| 9 | Hikal Ltd | 7.13 | -50.14 | Neutral | 220.00 | -3.95 | -49.00 |
| 10 | RPG Life Sciences Ltd | 7.12 | 37.20 | Neutral | 147.00 | 69.64 | 115.00 |
| 11 | Shilpa Medicare Ltd | 5.94 | 71.52 | Highly Overvalued | 435.00 | 6.80 | 243.00 |
| 12 | Strides Pharma Science Ltd | 5.55 | 16.97 | Undervalued | 925.00 | 19.92 | 575.00 |
| 13 | Jeena Sikho Lifecare Ltd | 5.52 | 28.20 | Neutral | 349.00 | 17.87 | 222.00 |
| 14 | Gufic BioSciences Ltd | 5.49 | 65.79 | Neutral | 151.00 | 6.30 | 64.00 |
| 15 | Dishman Carbogen Amcis Ltd | 5.38 | 29.23 | Neutral | 566.00 | -2.45 | 97.00 |
| 16 | Orchid Pharma Ltd | 4.85 | 234.05 | Neutral | 41.00 | 8.91 | 21.00 |
| 17 | Sequent Scientific Ltd | 4.61 | 301.49 | Overvalued | 162.00 | 1.74 | 32.00 |
| 18 | Sun Pharma Advanced Research Company Ltd | 4.35 | 4.12 | Neutral | 1599.00 | 47.83 | 1553.00 |
| 19 | Zota Health Care Ltd | 3.97 | -48.15 | Neutral | 19.00 | 8.06 | -74.00 |
| 20 | Procter & Gamble Health Ltd | 3.45 | 29.33 | Neutral | 466.00 | 215.00 | 357.00 |
| 21 | Sanofi India Ltd | 3.45 | 17.56 | Neutral | 491.00 | 134.52 | 413.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
Concall Report⬤7th Nov 25
Q2 FY26 Earnings Conference Call
BULLISH SENTIMENT
Jeena Sikho Lifecare Ltd is an Indian healthcare company focused on Ayurvedic products and services. It offers herbal remedies, health supplements, and wellness consultations under its 'Divine Herbal' brand. The company aims to promote natural healing and holistic well-being, operating through retail chains, clinics, and an online presence in the growing Indian wellness market.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Jeena Sikho Lifecare Ltd's P/E ratio (TTM) is 28.17, compared to the industry median of 30.91 and large cap median of 28.64.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Jeena Sikho Lifecare Ltd's P/B ratio is 13.39, compared to the industry median of 3.69 and large cap median of 3.11.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Jeena Sikho Lifecare Ltd's P/S ratio is 7.67, compared to the industry median of 3.74 and large cap median of 3.02.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Jeena Sikho Lifecare Ltd's PEG ratio is 2.50.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Jeena Sikho Lifecare Ltd's EV/EBITDA ratio is 17.21.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Jeena Sikho Lifecare Ltd's ROE is 47.54%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Jeena Sikho Lifecare Ltd's ROA is 51.78%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Jeena Sikho Lifecare Ltd's ROCE is 64%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Jeena Sikho Lifecare Ltd's operating margin is 43.57%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Jeena Sikho Lifecare Ltd's net margin is 27.72%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Jeena Sikho Lifecare Ltd's current ratio is 3.36.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Jeena Sikho Lifecare Ltd's debt-to-equity ratio is 0.27.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Jeena Sikho Lifecare Ltd's interest coverage ratio is 23.85.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Jeena Sikho Lifecare Ltd's DPS is ₹4.46.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Jeena Sikho Lifecare Ltd's EPS is 177.60.
(Source line: "Ratios as of 25 Sept 2026, based on last traded price of ₹503.45. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 2021
Headquarters: Panchkula, Haryana
Core Offerings: Ayurvedic products, Health supplements, Wellness consultations, Herbal FMCG, Online health services
Stock Listing: NSE (JSLL), BSE (544476)
Promoter: Dr. Dhananjay Datar & Family
2021: Incorporated as Jeena Sikho Lifecare Limited on November 10. 2022: Launched an IPO and listed on NSE SME platform in April, focusing on expanding its Ayurvedic and wellness product portfolio and retail footprint through Divine Herbal Clinics and stores.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Ayurvedic Products & Health Supplements | N/A | Operating Profit |
| Wellness Clinics & Consultations | N/A | Operating Profit |
Ayurvedic Products: Manufactures and markets a range of Ayurvedic medicines, herbal supplements, and health-focused FMCG products under brands like "Divine Herbal." These include products for various health conditions and general wellness.
Wellness Clinics & Consultations: Operates "Divine Herbal" clinics across various locations, offering personalized Ayurvedic consultations, therapies, and health management programs to promote holistic well-being.
Retail & E-commerce: Distributes its products through a network of company-owned stores, third-party retail channels, and a growing online presence to reach a wider customer base.
Dr. Dhananjay Datar (Chairman & Managing Director): Founder of Jeena Sikho Lifecare Ltd. A visionary entrepreneur with a strong background in Ayurveda and a commitment to promoting natural healthcare solutions.
No major subsidiaries reported.
No major recent corporate actions on record (other than its IPO).
The Jeena Sikho Lifecare Ltd share price today is ₹503.45 on NSE (JSLL), as of 26 Sept 2026.
As of 25 Sept 2026, Jeena Sikho Lifecare Ltd share price is ₹503.45, with previous close ₹503.45. Today's range is ₹503.45 to ₹503.45. The 52-week range is ₹485.10 to ₹809.
As of today, Jeena Sikho Lifecare Ltd's market cap is ₹6,142.09 crore (Mid Cap).
Jeena Sikho Lifecare Ltd's current P/E ratio is 28.17, compared to the PHARMACEUTICALS & BIOTECHNOLOGY sector average of 35.
Jeena Sikho Lifecare Ltd's current P/B ratio is 13.39.
Jeena Sikho Lifecare Ltd's current dividend yield is 0.89%. Last dividend of ₹0.00 per share was declared on N/A.
Jeena Sikho Lifecare Ltd's EPS (TTM) is ₹177.60.
Jeena Sikho Lifecare Ltd is an Indian healthcare company focused on Ayurvedic products and services. It offers herbal remedies, health supplements, and wellness consultations under its 'Divine Herbal' brand. The company aims to promote natural healing and holistic well-being, operating through retail chains, clinics, and an online presence in the growing Indian wellness market.
Jeena Sikho Lifecare Ltd is promoted by Dr. Dhananjay Datar & Family, holding 63.62% as of 25 Sept 2026.
Jeena Sikho Lifecare Ltd is listed on NSE (JSLL) and BSE (544476). Its next quarterly results are expected on August 2024 (for Q1 FY25).
Capital Expenditures (CapEx)
